Buscar resultados de ensayos clínicos
Hereditary Hemorrhagic Telangiectasia - 26 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia Condición: Hereditary Hemorrhagic Telangiectasia Fecha: 2010-07-07 |
Completed |
Nombre del estudio: Tranexamic Acid and Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Condición: Hereditary Hemorrhagic Telangiectasia Fecha: 2009-12-11 Intervenciones:
|
Completed |
Nombre del estudio: Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT) Condición: Hereditary Hemorrhagic Telangiectasia (HHT) Fecha: 2011-07-19 Intervenciones: Drug: Submucosal Bevacizumab 200 mg Bevacizumab, injected submucosally- 100 mg per nostril |
Completed |
Nombre del estudio: Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT) Condición: Hereditary Hemorrhagic Telangiectasia (HHT) Fecha: 2011-07-18 Intervenciones: Drug: Bevacizumab The bevacizumab will then be sprayed by the treating physician in the clinic, under di |
Active, not recruiting |
Nombre del estudio: Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic Telangiectasia Condición:
Fecha: 2011-11-28 Intervenciones: Drug: Thalidomide Eligible patients will receive thalidomi |
Completed |
Nombre del estudio: Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia Condición:
Fecha: 2011-07-01 Intervenciones: Drug: Sodium tetradecyl sulfate (sotradecol) 3% Sodium tetradecyl sulfate (STS) is mixed with air at a r |
Withdrawn |
Nombre del estudio: Ranibizumab for the Management of Recurrent Nosebleeds in Patients With Hereditary Hemorrhagic Telangiectasia (HHT) Condición:
Intervenciones: Drug: Ranibizumab Patients will be treated with a total of 4 applications of ranibizumab in a fine mist |
Withdrawn |
Nombre del estudio: Pomalidomide in Hereditary Hemorrhagic Telangiectasia and Transfusion-Dependent Vascular Ectasia: a Phase I Study Condición:
|
Completed |
Nombre del estudio: Study of the Natural History and Genotype-Phenotype Correlations of Hereditary Hemorrhagic Telangiectasia Patients Condición: Hereditary Hemorrhagic Telangiectasia Fecha: 2000-02-24 |
Terminated |
Nombre del estudio: Efficacy of a Bevacizumab Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Condición:
Fecha: 2014-04-01 Intervenciones:
|